A New Ray of Hope: Cannazo India's Breakthrough in Medical Cannabis for Multiple Sclerosis on Shark Tank India S3

Introduction to Cannazo India and its Mission

In 2021, the global market was valued to be around 5.7 billion US dollars while the CAGR of the global hemp market is estimated to be 14.04% from 2023 to 2030, showing tremendous growth. In 2023, the Asia-Pacific region (which includes India) contributed to 33% of the global hemp market.

Many companies have emerged which have tapped into the medical and nutritional properties of hemp, also known as medical cannabis. One such company is Cannazo India, which also appeared on Shark India Season 3.

Cannazo India is an Ayurvedic healthcare company based in India that uses medicinal cannabis to address various conditions. They aim to integrate the ancient wisdom of Ayurveda with modern-day science and technology to formulate a range of hemp-based medicinal products for pain management, palliative care, and neurological and autoimmune disorders.

Medical Cannabis: A Revolutionary Treatment for Multiple Sclerosis

Multiple sclerosis (MS) is an immune disorder causing damage to the spinal cord and brain. The immune system attacks the neurons which decreases the transmission speed of nerve signals, leading to reduced mobility and memory.

Medical cannabis (MC) consists of over 140 cannabinoids with research still going on. Two of these compounds are cannabidiol (CBD) and tetrahydrocannabinol (THC). FDA has approved two medications already and in India, MC (known as Vijaya) is partly regulated by the AYUSH Ministry.

They interact with the endocannabinoid system (ECS) of the body, consisting of cannabinoid (CB) receptors, CB1 and CB2. 

CBD interacts with CB2 receptors of the ECS and serotonin 1A receptor (5-HT1A) receptors of the nervous system to cause various pharmacological effects like decreased inflammation, decreased pain, reduced muscle spasticity, improved mobility, reduced stress and anxiety and improvement in sleep quality.

The Breakthrough Solution: Cannazo India's Innovative Product

Cannazo India makes numerous products for general wellness and health for specific diseases. These products range from full-spectrum CBD oils like Vijaya Ambrosia, Cannaronil and Muscle Aid which may help in decreasing MS symptoms like pain, numbness and muscle spasticity.

They also offer general wellness products like Astaxanthin softgels with potent antioxidant properties, Gut Health Tablets to relieve bloating and constipation, and Intensive Hair Repair oil to promote blood circulation to the scalp.

The Shark Tank India Experience

Cannazo India was the first medical cannabis company featured on Shark Tank India Season 3. Shark Tank provided Cannazo India with a national platform to highlight the importance of medical cannabis for medical and nutritional use.

By being featured on Shark Tank India, Cannazo India’s founders, Sukkrit Goel, Arzoo Puri and Kartik Sharma, raised awareness about the benefits of medical cannabis and the availability of CBD-based products which may help in the treatment of neurological disorders like epilepsy, and autoimmune disorders like multiple sclerosis.

Moreover, Shark India has helped Cannazo India reach a much wider audience. Merely 20 minutes after Cannazo India’s episode was aired, their website crashed despite having a cloud plan. Not only that, but the number of orders also increased by 4 to 5 times.

Impact on Patients and Healthcare Industry

Cannazo India has published numerous case reports testing the efficacy of their products for various conditions. 

The research team recently published a case series on “The effect of full-spectrum cannabis leaf extract on pain, inflammation, and quality of sleep: Case series” in the “Journal of Integrative Medicine and Research” showcasing medical cannabis extract’s effectiveness in managing pain and inflammation by studying its effect on c-reactive protein (CRP) levels, Numeric Pain Rating Scale, Ashworth Scale, and Regensburg Insomnia Scale .

A 54-year-old woman with persistent lower back pain reported that her pain became more manageable while doing daily activities after two weeks of using Cannazo India’s Full-Spectrum Tincture. Moreover, a 42-year-old female patient undergoing chemotherapy reported less nausea and vomiting upon using Cannazo India’s Cannaronil as an adjunctive therapy.

Cannazo India not only aims to improve patient health but also to increase awareness about the use of medical cannabis for numerous health conditions like asthma and chronic pain along with general health and well-being.

Future Plans and Research

Cannazo India is driven to conduct more research on medical cannabis to unleash its full potential for the management of different health issues.

Head on to their blog which highlights the use of medical cannabis for the treatment of various health conditions like asthma, arthritis, multiple sclerosis, etc.

Medical cannabis leaf extract-based consumption medicines are Schedule E and, therefore prescribed through a network of registered medical practitioners. Cannazo India believes in educating the medical fraternity to create awareness about the efficacy and usage of medical cannabis for health issues and how it can be integrated with conventional medicine. 

They have served as a pioneer in educating the medical fraternity and consumers via conducting continuing medical education (CMEs) and plan to reach an even wider audience in the near future.

Regulatory and Market Perspectives

When thinking of medical cannabis, people usually assume that it is psychoactive, i.e., it will cause hallucinations. However, that is true for only certain parts of medical cannabis.

In India, the Narcotic Drugs and Psychotropic Substances Act of 1985 banned the use of flowering tops of cannabis, however, AYUSH approved the use of its leaves and seeds for medicinal use. In 2018, the Ministry of Health and Family Welfare approved the medical use of cannabis.

Cannazo India’s products are made from leaves that are approved by the government. Moreover, their products also pass through stringent third-party laboratory testing to approve their quality. This ensures that their products are of the highest quality and safe for consumption while delivering maximum efficacy.

Strategic Partnerships and Collaborations

Cannazo India has partnered with numerous institutions and bodies to increase awareness about the medical benefits of medical cannabis. Some of these parties include the Council of Scientific & Industrial Research - Central Drug Research Institute (CSIR-CDRI) and Panjab University.

CSIR has always lent Cannazo India a guiding hand in the pharmaceutical industry, and their recent collaboration with the University Institute of Pharmaceutical Sciences at Panjab University is to conduct medical research.

They have also collaborated with Dr. Sudhakar Nataranjan from the Indo-Tibetan Border Police (ITBP) to conduct animal studies for osteoarthritis/hip dysplasia in dogs using Cannazo India’s CBD pet oil.

Conclusion

A growing body of scientific evidence has introduced an alternative treatment option, offering new hope to people suffering from various medical conditions. Cannazo India, the first medical cannabis company to be featured on Shark Tank India, has raised national awareness about the use of medical cannabis for managing conditions such as chronic pain, asthma, arthritis, and anxiety.

As an Indian startup, they constantly strive to produce the best products while collaborating with institutes like CSIR-CDRI to bring Ayurvedic, plant-based healthcare options to the public.

Read More News :

India Offers Immense Investment Opportunities for Australian Green Companies

India Joins Citizen Astronaut Programme with SERA and Blue Origin